May 6, 2025
May 6, 2025
RapidPulse Announces Patient Enrollment Initiated in Pivotal Ischemic Stroke Study
Apr 8, 2025
Comanche Biopharma Announces European Medicines Agency (EMA) Has Granted Orphan Drug Designation for CBP-4888 in sFlt1-mediated Preterm Preeclampsia
Apr 8, 2025
Puzzle Medical Devices is Thrilled to Announce the Closing of its CAN$43 Million Round to Complete its Clinical Study Led by KF Matheson and Desjardins Capital
Jan 8, 2025
Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Jan 7, 2025